Literature DB >> 15987333

Ghost writing initiated by commercial companies.

.   

Abstract

Keywords:  Biomedical and Behavioral Research

Mesh：

Year:  2005        PMID： 15987333      PMCID： PMC1490135          DOI： 10.1111/j.1525-1497.2005.41015.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  19 in total

1.  Comments on "The corporate author".

Authors:  Cindy W Hamilton; Marianne Mallia-Hughes; Devora Mitrany; Mary Ann Foote
Journal:  J Gen Intern Med       Date:  2005-10       Impact factor: 5.128

2.  Scientific discourse, corporate ghostwriting, journal policy, and public trust.

Authors:  William M Tierney; Martha S Gerrity
Journal:  J Gen Intern Med       Date:  2005-06       Impact factor: 5.128

Review 3.  Advancing a program of research within a nursing faculty role.

Authors:  Marie T Nolan; Jennifer Wenzel; Hae-Ra Han; Jerilyn K Allen; Kathryn A Paez; Victoria Mock
Journal:  J Prof Nurs       Date:  2008 Nov-Dec       Impact factor: 2.104

4.  Five years before the masthead: our journey with the Journal of General Internal Medicine.

Authors:  William M Tierney; Martha S Gerrity; Cindy Byrne
Journal:  J Gen Intern Med       Date:  2009-12       Impact factor: 5.128

5.  Exorcising ghostwriting…. Ghostwriting could potentially have serious repercussions for science and should therefore be treated as research misconduct.

Authors:  Xavier Bosch
Journal:  EMBO Rep       Date:  2011-05-13       Impact factor: 8.807

6.  Ghost busting--taking the sheet off the ghost.

Authors:  R J Moots; K Wilson; E D Silverman
Journal:  Z Rheumatol       Date:  2016-04       Impact factor: 1.372

7.  Transgression in scientific communication.

Authors:  Pf Kotur
Journal:  Indian J Anaesth       Date:  2010-01

Review 8.  A concern that drug companies cannot ignore.

Authors:  Elizabeth Wager
Journal:  J R Soc Med       Date:  2005-10       Impact factor: 18.000

9.  Investigator experiences with financial conflicts of interest in clinical trials.

Authors:  Paula A Rochon; Melanie Sekeres; John Hoey; Joel Lexchin; Lorraine E Ferris; David Moher; Wei Wu; Sunila R Kalkar; Marleen Van Laethem; Andrea Gruneir; Jennifer Gold; James Maskalyk; David L Streiner; Nathan Taback; An-Wen Chan
Journal:  Trials       Date:  2011-01-12       Impact factor: 2.279

10.  Ghostwriting: the dirty little secret of medical publishing that just got bigger.

Authors: 
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.